Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Lpath initiates dosing in phase I clinical trial of iSONEP in AMD

Oct. 21, 2008

Santen receives Japanese approval for Tapros in glaucoma and ocular hypertension

Oct. 20, 2008

Alcon signs licensing agreement with GSK for cilomilast and expands alliance with Origenis

Oct. 17, 2008

Sirion presents pivotal uveitis data for Durezol

Oct. 17, 2008

New therapeutic agents for eye disorders imparted in recent Santen patent

Oct. 17, 2008

Sirion launches Durezol for postoperative ocular inflammation and pain

Oct. 16, 2008

Pfizer launches Macugen for age-related macular degeneration in Japan

Oct. 15, 2008

QLT initiates phase I trial of synthetic retinoid product QLT-091001

Oct. 10, 2008

Phase I trial of Inspire's INS-117548 for glaucoma begins

Oct. 10, 2008

Lux licenses from Isotechnika global rights to voclosporin in all ophthalmic indications

Oct. 9, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...